Effect of high versus low initial doses of L-thyroxine for congenital hypothyroidism on thyroid function and somatic growth

Archives of Disease in Childhood

Volumn 93, Issue 11, 2008, Pages 940-944

  Jones, J H ^a   Gellen B ^a,b   Paterson, W F ^a   Beaton, S ^a   Donaldson, Malcolm D C ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROTROPIN; THYROXINE;

ANTHROPOMETRY; ARTICLE; BODY GROWTH; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID FUNCTION;

ANTHROPOMETRY; BIRTH WEIGHT; CONGENITAL HYPOTHYROIDISM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GROWTH; HUMANS; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; THYROID GLAND; THYROTROPIN; THYROXINE; TREATMENT OUTCOME;

EID: 55349084063     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2007.120618     Document Type: Article

References (25)

1. Dubuis J-M, Glorieux J, Richer F, et al. Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment. J Clin Endocrinol Metab 1996;81:222-7.
2. Selva KA, Harper A, Downs A, et al. Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH. J Pediatr 2005;147:775-80.
3. Bongers-Schokking JJ, Koot HM, Wiersma D, et al. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr 2000;136:292-7.
4. Tillotson SL, Fuggle PW, Smith I, et al. Relation between biochemical severity and intelligence in early-treated congenital hypothyroidism: a threshold effect. BMJ 1994;309:440-5.
5. Rovet JF, Ehrlich RM. Long-term effects of L-thyroxine therapy for congenital hypothyroidism. J Pediatr 1995;126:380-6.
6. Daneman D, Howard NJ. Neonatal thyrotoxicosis: intellectual impairment and craniosynostosis in later years. J Pediatr 1980;97:257-9.
7. Buckler JMH, Willgerodt H, Keller E. Growth in thyrotoxicosis. Arch Dis Child 1986;61:464-71.
8. Ray M, Muir TM, Murray 6D, et al. Audit of screening programme for congenital hypothyroidism in Scotland 1979-93. Arch Dis Child 1997;76:411-15.
9. Jones JH, Mackenzie J, Croft GA, et al. Improvement in screening performance and diagnosis of congenital hypothyroidism in Scotland 1979-2003. Arch Dis Child 2006;91:680-5.
10. Oakley GA, Muir T, Ray M, et al. Increased incidence of congenital malformations in children with transient thyroid-stimulating hormone elevation on neonatal screening. J Pediatr 1998;132:726-30.
11. Tillotson SL, Grant DB, Ades AE. Plasma total thyroxine and free thyroxine concentrations in congenital hypothyroidism before and during treatment. J Clin Pathol 1992;45:819-20.
12. Cole TJ, Freeman JV, Preece MA. British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. Stat Med 1998;17:407-09.
13. Rovet JF. Long-term neuropsychological segualae of early-treated congenital hypothyroidism: effects in adolescence. Acta Paediatr Suppl 1999;432:88-95.
14. Kempers MJE, Van der Sluijs Veer L, Nijhuis-van der Sanden MWG, et al. Intellectual and motor development of young adults with congenital hypothyroidism diagnosed by neonatal screening. J Clin Endocrinol Metab 2006;91:418-24
15. Kooistra L, Laane C, Vulsma T, et al. Motor and cognitive development in children with congenital hypothyroidism: a long-term evaluation of the effects of neonatal treatment. J Pediatr 1994;124:903-9.
16. Léger J, Larroque B, Norton J. Influence of severity of congenital hypothyroidism and adeguacy of treatment on school achievement in young adolescents: a population-based cohort study. Acta Paediatr 2001;90:1249-56.
17. Boileau P, Rain P, Rives S, et al. Earlier onset of treatment or increment in LT4 dose in screened congenital hypothyroidism: which was the more important factor for IQ at 7 years? Horm Res 2004;61:228-33.
18. Oerbeck B, Sundet K, Kate BF, et al. Congenital hypothyroidism: no adverse effects of high dose thyroxine treatment on adult memory, attention, and behaviour. Arch Dis Child 2005;90:132-7.
19. Bongers-Schokking JJ, de Muinck Keizer-Schrama SMPF. Influence of timing and dose of thyroid hormone replacement on mental, psychomotor, and behavioural development in children with congenital hypothyroidism. J Pediatr 2005;147:768-74.
20. Hindmarsh PC. Optimisation of thyroxine dose in congenital hypothyroidism. Arch Dis Child 2002;86:73-5.
21. Glorieux J, Desjardins M, Letarte J, et al. Useful parameters to predict the eventual mental outcome of hypothyroid children. Pediatr Res 1988;24:6-8.
22. Ng SM, Wong SC, Didi M. Head circumference and linear growth during the first 3 years in treated congenital hypothyroidism in relation to aetiology and initial biochemical severity. Clin Endocrinol 2004;61:155-9.
23. Aronson R, Ehrlich RM, Bailey J, et al. Growth in children with congenital hypothyroidism detected by neonatal screening. J Pediatr 1990;116:33-7.
24. Grant DB. Growth in early-treated congenital hypothyroidism. Arch Dis Child 1994;70:464-8.
25. Nelson JC, Clark SJ, Borut DL, et al. Age-related changes in serum free thyroxine during childhood and adolescence. J Pediatr 1993;123:899-905.